about
Multifunctional Nanocarriers for diagnostics, drug delivery and targeted treatment across blood-brain barrier: perspectives on tracking and neuroimagingThe Impact of Variables on Particle Size of Solid Lipid Nanoparticles and Nanostructured Lipid Carriers; A Comparative Literature ReviewC-terminal domain deletion enhances the protective activity of cpa/cpb loaded solid lipid nanoparticles against Leishmania major in BALB/c miceInfluence of surfactant and lipid type on the physicochemical properties and biocompatibility of solid lipid nanoparticles.Nanoparticles and the immune systemSurface engineering of macrophages with nanoparticles to generate a cell-nanoparticle hybrid vehicle for hypoxia-targeted drug delivery.Liposome encapsulation of thiol-capped CdTe quantum dots for enhancing the intracellular delivery.Lipid-based nanoparticles as pharmaceutical drug carriers: from concepts to clinicNanocarrier for poorly water-soluble anticancer drugs--barriers of translation and solutions.In vivo biodistribution, anti-inflammatory, and hepatoprotective effects of liver targeting dexamethasone acetate loaded nanostructured lipid carrier systemNovel method to label solid lipid nanoparticles with 64cu for positron emission tomography imaging.Gene therapy for C-26 colon cancer using heparin-polyethyleneimine nanoparticle-mediated survivin T34A.Accelerated blood clearance phenomenon upon cross-administration of PEGylated nanocarriers in beagle dogs.Formulation and optimization of solid lipid nanoparticle formulation for pulmonary delivery of budesonide using Taguchi and Box-Behnken designNanostructured lipid carriers (NLC) for parenteral delivery of an anticancer drugSolid Lipid Nanoparticles (SLNs) for Intracellular Targeting ApplicationsEvaluation of a nanoemulsion formulation strategy for oral bioavailability enhancement of danazol in rats and dogs.Toxicity of nanomaterials to the eye.Nanomedicine-based neuroprotective strategies in patient specific-iPSC and personalized medicine.Development of ionic-complex-based nanostructured lipid carriers to improve the pharmacokinetic profiles of breviscapineNanoparticulate systems for drug delivery and targeting to the central nervous system.Drug delivery to the CNS and polymeric nanoparticulate carriers.Nanocarrier possibilities for functional targeting of bioactive peptides and proteins: state-of-the-art.Improving the transport of chemotherapeutic drugs across the blood-brain barrier.Leishmaniasis: focus on the design of nanoparticulate vaccine delivery systems.Lipid nanoparticles for chemotherapeutic applications: strategies to improve anticancer efficacy.Toxico-/biokinetics of nanomaterials.Lipid nanoparticles for cancer therapy: state of the art and future prospects.Solid lipid nanoparticle-based calix[n]arenes and calix-resorcinarenes as building blocks: synthesis, formulation and characterization.Pharmaceutical and biomedical applications of lipid-based nanocarriers.Nanostructured lipid carriers and their current application in targeted drug delivery.Current strategies for DNA therapy based on lipid nanocarriers.Formulation design for topical drug and nanoparticle treatment of skin disease.Exploitation of lipid-polymeric matrices at nanoscale for drug delivery applications.Nanocarrier mediated retinal drug delivery: overcoming ocular barriers to treat posterior eye diseases.Improved pharmacokinetics and enhanced tumor growth inhibition using a nanostructured lipid carrier loaded with doxorubicin and modified with a layer-by-layer polyelectrolyte coating.Nano-based strategies to overcome p-glycoprotein-mediated drug resistance.Curcumin-loaded nanostructured lipid carriers (NLCs) for nasal administration: design, characterization, and in vivo study.Novel nanostructured lipid carrier co-loaded with doxorubicin and docosahexaenoic acid demonstrates enhanced in vitro activity and overcomes drug resistance in MCF-7/Adr cells.Caveolar uptake and endothelial-protective effects of nanostructured lipid carriers in acid aspiration murine acute lung injury.
P2860
Q21223671-A724C196-0ADF-4319-8DA0-0D18CB2A0713Q26740190-C982A2AE-DFA6-441B-998F-001E1BD9410CQ28478982-3B72E74E-C16C-4DA1-A8EA-9CEB03AE3B1CQ30432397-74632816-F390-4A35-B0AE-44DEA170CA9EQ33634320-F6B44FF7-7F59-475E-A9AB-3E361C8C7F9EQ33644844-D6EF0190-548D-41A6-B468-CD43A53C2864Q33847994-9C7426BA-A55C-46D4-9FAD-C6D63B3357A7Q33911056-710CD91F-3142-4225-9A45-6282514FE588Q33962553-58ECA10F-C800-4C2E-BE88-1FEC1A788010Q34177551-719FCFED-925F-4497-A2BF-04BA01F5BA1AQ34906375-7F3861EE-26B1-4624-8F6E-307B3CBEE7CCQ35488154-28D9FA18-18A1-4520-BEF4-6BC7150589B5Q35624235-5A2EC2B0-971A-4260-B4CA-38A311147A62Q35796474-DF139D69-AAFB-4C70-A199-02ACCD9F4967Q35821866-D0D10201-D283-4FB4-942A-5629C54886ABQ36408352-F7DB844A-3C11-47F9-ACBF-455B2D9A9CA7Q37171319-0868C997-A90E-41F9-AB27-15F88464B393Q37676123-A4C0753E-CEBE-41EB-81E1-6590A841415CQ37684006-93FC1524-B66E-4999-9495-16828C837FA2Q37729317-79A751C3-8F86-4171-899A-6F2A1B8137CEQ37800505-7011F95A-510D-4153-9235-34691A97B6C6Q37856301-BAA85FB3-4693-4CCD-B949-79D2B4DC1498Q37948968-53FC6D03-590D-48C3-BF1C-32ED13DAC3ABQ37960529-72E3595A-459A-4A0B-A3CB-C3C9118FEE32Q37965724-2A80A345-5550-4712-98AD-A0313A1A8F0CQ38007182-FCF459E0-4D84-412F-9188-FEC9F4503E5DQ38009230-013D3511-5D5C-4817-8538-822CD106E297Q38040884-66F5E38E-2B0D-4822-A4C2-8E9A45E3557BQ38160303-E15ACD74-B6A3-4686-92A5-478B66658B22Q38192709-361FC58F-1535-4B35-B705-0BF89AF9AF9DQ38210565-E3FAF434-8127-468D-939D-78B3550AADA7Q38232143-5B31045B-138C-40FE-8D19-B5B2C55A55D4Q38358872-29B0BD07-D5EF-415A-99DD-C9CFE1025FDEQ38816436-443D30D5-5B64-4DA7-B737-8D7B7E535BC0Q38829320-5D91BC91-096A-4FDA-B64B-4132CC7EF33AQ38839118-F2F8DB8C-2BCF-4F98-871A-D7991483E44BQ38856533-00C8CE7D-C2E6-4D01-8D24-6AB012F55BB7Q38943035-9F9A4F6C-DB4C-4BF4-AEAE-199E4F8AA7DFQ39024424-A5FAC9AA-6D9B-4900-A4F9-6E6FEE54AC68Q39172372-585014DB-5A2B-496D-9AC7-C11FCB160122
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 13 September 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Lipid nanoparticles for parenteral delivery of actives.
@en
Lipid nanoparticles for parenteral delivery of actives.
@nl
type
label
Lipid nanoparticles for parenteral delivery of actives.
@en
Lipid nanoparticles for parenteral delivery of actives.
@nl
prefLabel
Lipid nanoparticles for parenteral delivery of actives.
@en
Lipid nanoparticles for parenteral delivery of actives.
@nl
P1476
Lipid nanoparticles for parenteral delivery of actives
@en
P2093
Rainer H Müller
P304
P356
10.1016/J.EJPB.2008.09.003
P407
P50
P577
2008-09-13T00:00:00Z